PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/3/2003
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 31/03/2003 |
| Quarter | 1 |
| Financial Year End | 31/12/2003 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/03/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/03/2003 | 31/03/2002 | 31/03/2003 | 31/03/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 154,525 | 140,676 | 154,525 | 140,676 |
| 2 | Profit/(loss) before tax | 17,913 | 13,492 | 17,913 | 13,492 |
| 3 | Profit/(loss) after tax and minority interest | 11,646 | 7,342 | 11,646 | 7,342 |
| 4 | Net profit/(loss) for the period | 11,646 | 7,342 | 11,646 | 7,342 |
| 5 | Basic earnings/(loss) per share (sen) | 11.60 | 7.30 | 11.60 | 7.30 |
| 6 | Dividend per share (sen) | 0.00 | 0.00 | 0.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.9200 | 1.8000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 20 May 2003 |
| Category | Financial Results |
| Reference No | CR-030519-31900 |